1.Induction of apoptosis by Tryptanthrin on K562 cells
Shan MIAO ; Hai ZHANG ; Xiaopeng SHI ; Jiyuan SUN ; Xuanxuan ZHOU ; Jiepin WANG ; Qing MIAO ; Yanhua XIE ; Siwang WANG
Chinese Pharmacological Bulletin 1987;0(02):-
Aim To study the effect of Tryptanthrin(Try) on proliferation and apoptosis of erythroleukemia K562 cells.Methods The cell proliferation effect of Try(1.56~50 mg?L-1) on K562 cells was assessed by MTT assay.The morphologic change was observed by Hoechst 33258 fluore-scent stain.The flow cytometer was used to detect cell apoptosis and cell cycle.Results MTT showed that in the range of 3.12~50 mg?L-1 Try obviously inhibited the proliferation of K562 cells in a dose and time-dependent manner.Typical apoptosis changes were observed in K562 cells treated with Try for 48 h by flourescence inverted microscope.With Annexin V-FITC and PI double staining,folw cytometer result showed that the apoptosis state was obvious in K562 cells treated with 25,50 mg?L-1 Try for 48 h.The cell cycle distribution of K562 was changed.The G0/G1 phase was blocked and the DNA synthesis was inhibited,accompanied with subdiploid apoptotic peak.Conclusion Try has an effect on inhibiting the cell proliferation and inducing the apoptosis of K562.
2.Application of shear wave elastography in cervical cancer
Manting ZENG ; Jihua LIU ; Ningbo ZHOU ; Jian WANG ; Xuanxuan LI ; Hong ZHU
Journal of International Oncology 2019;46(2):117-120
Shear wave elastography (SWE) is used to quantitatively analyze the hardness of the tissue by Young's modulus.The hardness of the tissue is visualized in the form of color coding to distinguish the benign and malignant tissue detected.SWE has higher sensitivity,accuracy and specificity compared with traditional color doppler,which is more objective than elastography,safer,cheaper and simpler than MRI.SWE has a good application prospect in the diagnosis,clinical staging and curative effect monitoring of cervical cancer.
3.Prokaryotic expression and serological analysis of the head domain of influenza A virus hemagglutinin
Xuanxuan NIAN ; Jing LIU ; Tao DENG ; Junying LI ; Rong ZHOU ; Guomei ZHANG ; Ning MA ; Zhegang ZHANG ; Jiayou ZHANG ; Xiaoming YANG
Chinese Journal of Microbiology and Immunology 2022;42(11):857-864
Objective:To express the head domain of influenza A virus hemagglutinin (HA) in a prokaryotic expression system and to evaluate its immunogenicity.Methods:The genes encoding the HA head domains of H1N1 and H3N2 influenza viruses were cloned into pET-22b(+ ) prokaryotic expression plasmid. After the induction with IPTG, the fusion proteins rH1N1-HA and rH3N2-HA containing HA head domain and His-tag were expressed and obtained from E. coli BL21. SDS-PAGE and Western blot was used to verify the expression of the recombinant proteins. Rabbits were immunized with multiple doses of the purified recombinant proteins to obtain polyclonal antibodies against the HA head domains of H1N1 and H3N2. The immunogenicity of the recombinant proteins was evaluated in BALB/c mice. Results:rH1N1-HA and rH3N2-HA induced protective antibodies (geometric mean titer ≥40) in mice and could be used as protective antigens. Polyclonal antibodies against rH1N1-HA and rH3N2-HA could be used as important materials for Western blot, ELISA and other immunological assays.Conclusions:The HA head domains prepared in this study could be used as protective antigens to induce protective antibodies in mice. Polyclonal antibodies against the HA head domains could be used for immunological and serological studies of influenza A viruses.
4.Preparation and immunogenicity evaluation of recombinant influenza hemagglutinin trimer vaccine
Guomei ZHANG ; Jing LIU ; Ning MA ; Rong ZHOU ; Yang LE ; Zhegang ZHANG ; Xuanxuan NIAN ; Xuedan LI ; Jiayou ZHANG ; Yangyang ZHANG ; Sheng LI ; Hu HUANG ; Xiaoming YANG
Chinese Journal of Microbiology and Immunology 2023;43(2):137-143
Objective:To prepare a recombinant hemagglutinin trimer (HA-Tri) vaccine against influenza viruses and to study its immunogenicity in a mouse model.Methods:A stable CHO cell line that could express HA-Tri was constructed. Western blot, single radial immunodiffusion, protein particle size detection and N-glycosylation site analysis were performed for qualitative and quantitative analysis of the recombinant protein. According to the different treatment conditions such as dosage and adjuvant, BALB/c mice were divided into 11 groups and subjected to consistent immunization procedures. Serum neutralizing antibody titers were measured on 56 d after the first immunization to evaluate the immunogenicity of HA-Tri.Results:The constructed CHO cells could secret and express HA-Tri proteins. The HA-Tri proteins were biologically active and capable of forming precipitation rings in the single radial immunodiffusion. The particle size of HA-Tri was approximately 18.79 nm and 10 N-glycosylation sites were detected, including high mannose, complex glycoforms and heterozygous glycoforms. After prime-boost immunization, there was no statistically significant difference in the titers of neutralizing antibodies induced in mice by 3.75 μg of HA-Tri in combination with RFH01 adjuvant and 15 μg of monovalent vaccine stock solution ( P=0.431 2, U=36). Serum antibody titers in the HA-Tri+ RFH01 groups were higher than those in the corresponding HA-Tri groups without RFH01 adjuvant, and the highest titer was induced in the 15 μg HA-Tri+ RFH01 group, which was 1 280. Conclusions:The recombinant HA-Tri protein was successfully prepared. HA-Tri in combination with RFH01 adjuvant could induce humoral immune responses against influenza viruses in BALB/c mice, which would provide reference for the development of influenza virus recombinant subunit vaccines.
5.Immunogenicity of quadrivalent influenza virus subunit vaccine combined with RFH01 adjuvant in mice
Rong ZHOU ; Ning MA ; Guomei ZHANG ; Yang LE ; Xuanxuan NIAN ; Xuedan LI ; Lanxin JIA ; Jiayou ZHANG ; Yangyang ZHANG ; Xiaoming YANG
Chinese Journal of Microbiology and Immunology 2023;43(5):351-359
Objective:To evaluate the immunogenicity of a quadrivalent subunit vaccine combined with RFH01 adjuvant in a mouse model.Methods:Identification tests were performed on four monovalent influenza virus subunit vaccine stock solutions according to the methods described in Part 3 of the Chinese Pharmacopoeia 2020 Edition. In the study of the quadrivalent subunit vaccine combined with RFH01 adjuvant, 460 female BALB/c mice (6-8 weeks old) were randomly divided into 46 groups including experimental groups, vaccine control group, negative control group and blank group with 10 mice in each group. In the study of the quadrivalent subunit vaccine in old and young mice, 80 female 10-month-old and 80 female 10-week-old BALB/c mice were randomly divided into 16 groups ( n=10) including monovalent influenza virus vaccine group, quadrivalent subunit vaccine group, quadrivalent subunit vaccine+ RFH01 adjuvant group, chicken embryo quadrivalent split vaccine control group and PBS group. All mice were immunized by intramuscular injection. At 21 d after the primary immunization, a booster immunization was conducted using the same strategy. Blood samples were collected at 21 d and 42 d after the primary immunization for serum separation. Haemagglutination inhibition (HI) test was performed to detect the antibody levels in mouse serum samples. Results:After the booster immunization, the positive conversion rates in all vaccine+ RFH01 adjuvant groups reached 100%, and the geometric mean titers (GMTs) of serum antibodies were significantly higher than those of the vaccine groups without RFH01 adjuvant. There were significant differences in serum antibody titers between the monovalent/quadrivalent subunit vaccine groups with and without RFH01 adjuvant. After the booster immunization, the titers of serum antibodies against H1N1, H3N2, B/Victoria and B/Yamagata in the 10-week-old mice were significantly higher than those in the 10-month-old mice.Conclusions:The monovalent and quadrivalent influenza virus vaccines in combination with RFH01 adjuvant could elicit higher antibody titers in young (6-10 weeks old) and old (10 months old) mice, showing good immunogenicity.
6.Preoperative evaluation and treatment methods of non-firearm penetrating brain injury in children
Xuanxuan WU ; Yunying YANG ; Yudong ZHOU ; Lusheng LI ; Xuan ZHAI ; Ping LIANG
Chinese Journal of Neuromedicine 2021;20(10):1022-1026
Objective:To investigate the preoperative evaluation and treatment methods of non-firearm penetrating brain injury (PBI) in children.Methods:A retrospective analysis was performed. The clinical data of 18 children with non-firearm PBI admitted to our hospital from January 2012 to December 2020 were collected.Results:CT angiography was performed in 10 patients and MRI in 8 patients before treatment. CT angiography indicated that the intracranial large vessels were not injured by the foreign bodies. The foreign bodies of 7 patients were removed by craniotomy and the foreign bodies of 3 patients were removed directly under general anesthesia; the foreign bodies of 8 patients were removed directly outside the hospital without anesthesia. Cerebrospinal fluid leakage was noted in 4 patients and intracranial infection in 7 patients after surgery; no foreign body residue or intracranial hemorrhage after surgery was noted. After 3-69 months of follow-up, 3 patients had visual decline, one had limited eye movement, and one had olfactory decline.Conclusion:CT angiography is a safe and effective evaluation method for children with non-firearm PBI, and direct extraction of foreign body under general anesthesia is a feasible surgical method when CT angiography shows that the blood vessels are not hurted by the foreign bodies.